![Stephen Toovey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Toovey
Directeur/Bestuurslid bij 60 DEGREES PHARMACEUTICALS, INC.
Vermogen: 4 088 $ op 31-05-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Geoffrey Dow | M | 50 | 14 jaar | |
Zheng Wu | M | 60 |
Shanghai Ark Biopharmaceutical Co., Ltd.
![]() Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | 10 jaar |
Charles Allen | M | 48 | 1 jaar | |
Tyrone Miller | M | 50 | 10 jaar | |
Paul Field | M | 61 | 1 jaar | |
Kristen Landon | F | 57 | - | |
Bryan Smith | M | 58 | 8 jaar | |
Xu Cheryl | M | 56 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Wu Zheng Bo | M | - |
Shanghai Ark Biopharmaceutical Co., Ltd.
![]() Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | - |
Hong Qin | F | 57 |
Shanghai Ark Biopharmaceutical Co., Ltd.
![]() Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | 2 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
China | 3 | 30.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Stephen Toovey
- Persoonlijk netwerk